Toray Industries, Inc
22
3
4
16
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
9.1%
2 terminated/withdrawn out of 22 trials
88.9%
+2.4% vs industry average
9%
2 trials in Phase 3/4
19%
3 of 16 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
A Study of TRK-950 in Patients With Advanced Solid Tumors
Role: lead
Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC)
Role: collaborator
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
Role: lead
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
Role: lead
A Phase 1 Study Evaluating the Safety of TRK-950 in Patients With Advanced Solid Tumors
Role: lead
Pilot Clinical Study of NOA-001 for ARDS (Acute Respiratory Distress Syndrome)
Role: lead
Safety, Tolerability, and Pharmacokinetic Study of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis
Role: lead
A Study to Investigate the Safety and Efficacy of TRK-750 for the Treatment of Patients With CIPN (Chopin Study)
Role: lead
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Role: lead
Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), Food-effect of TRK-750
Role: lead
Efficacy and Safety of TRK-700 in Patient With Post-Herpetic Neuralgia
Role: lead
TRK-700 Drug-Drug Interaction Study With Digoxin and Midazolam
Role: lead
TRK-820 Study in Subjects on Hemodialysis With or Without Uremic Pruritus
Role: lead
TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
Role: lead
TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
Role: lead
A Study of TRK-170 for the Treatment of Crohn's Disease
Role: lead
A Pharmacokinetic Study of TRK-100STP in Japanese Patients With Renal Impairment
Role: lead
Efficacy and Safety Study of TRK-820 to Treat Conventional-treatment-resistant Pruritus in Patients Receiving Hemodialysis
Role: collaborator
Study to Compare Pharmacokinetic Profiles of TRK-100STP in Japanese, Chinese, and South Korean Non-elderly Healthy Adult Males
Role: collaborator
Safety Study of TRK-820 for Patient With Hemodialysis
Role: collaborator